Superior Industrial Enterprises Limited (BOM:519234)
52.35
+2.19 (4.37%)
At close: Jul 29, 2025
Checkpoint Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 42.46 | 1.2 | 1.53 | 0.6 | 0.82 | Upgrade |
Short-Term Investments | - | 36.53 | 26.47 | 17.37 | 14.62 | Upgrade |
Cash & Short-Term Investments | 42.46 | 37.73 | 28 | 17.97 | 15.44 | Upgrade |
Cash Growth | 12.54% | 34.75% | 55.86% | 16.35% | -7.53% | Upgrade |
Accounts Receivable | 71 | 57.11 | 28.67 | 45.88 | 38.85 | Upgrade |
Other Receivables | - | 0.41 | 0.49 | - | 2.52 | Upgrade |
Receivables | 72.04 | 58.42 | 30.52 | 48.24 | 43.55 | Upgrade |
Inventory | 48.12 | 53.56 | 83.48 | 42.27 | 37.44 | Upgrade |
Prepaid Expenses | - | 0.08 | 0.06 | 0.09 | 0.02 | Upgrade |
Other Current Assets | 4.18 | 6.17 | 6.27 | 4.27 | 5.27 | Upgrade |
Total Current Assets | 166.8 | 155.96 | 148.32 | 112.84 | 101.71 | Upgrade |
Property, Plant & Equipment | 58.58 | 58.81 | 62.1 | 64.7 | 67.88 | Upgrade |
Long-Term Investments | 1,368 | 1,004 | 719.56 | 669.93 | 632.47 | Upgrade |
Long-Term Deferred Tax Assets | 2.43 | 1.69 | 2.82 | 1.49 | 1.66 | Upgrade |
Other Long-Term Assets | 9.3 | 9.34 | 9.8 | 1.81 | 1.81 | Upgrade |
Total Assets | 1,605 | 1,230 | 942.6 | 850.76 | 805.53 | Upgrade |
Accounts Payable | 42.08 | 20.25 | 23.84 | 26.34 | 32.91 | Upgrade |
Accrued Expenses | 2.54 | 5.78 | 6.29 | 4.56 | 2.12 | Upgrade |
Short-Term Debt | - | 57.76 | 74.17 | 51.57 | 48.45 | Upgrade |
Current Portion of Long-Term Debt | 36.76 | 1.92 | 3.11 | 2.58 | - | Upgrade |
Current Income Taxes Payable | 3.34 | 5.72 | 4.99 | 0.21 | - | Upgrade |
Other Current Liabilities | 1.06 | 0.37 | 0 | - | 3.53 | Upgrade |
Total Current Liabilities | 85.78 | 91.8 | 112.41 | 85.26 | 87.01 | Upgrade |
Long-Term Debt | 55.09 | 56.49 | 58.21 | 61.35 | 59.02 | Upgrade |
Other Long-Term Liabilities | 2.08 | 0.05 | 0.07 | 0.98 | 0.98 | Upgrade |
Total Liabilities | 142.95 | 149.88 | 171.93 | 148.47 | 147.68 | Upgrade |
Common Stock | 138.5 | 138.5 | 138.5 | 138.5 | 138.5 | Upgrade |
Additional Paid-In Capital | - | 199.5 | 199.5 | 199.5 | 199.5 | Upgrade |
Retained Earnings | - | 306.48 | 254.82 | 232.62 | 212.52 | Upgrade |
Comprehensive Income & Other | 1,292 | 408.86 | 157.79 | 121.99 | 110.83 | Upgrade |
Total Common Equity | 1,431 | 1,053 | 750.6 | 692.61 | 661.35 | Upgrade |
Minority Interest | 31.61 | 26.84 | 20.07 | 9.68 | -3.5 | Upgrade |
Shareholders' Equity | 1,462 | 1,080 | 770.67 | 702.29 | 657.84 | Upgrade |
Total Liabilities & Equity | 1,605 | 1,230 | 942.6 | 850.76 | 805.53 | Upgrade |
Total Debt | 91.85 | 116.17 | 135.49 | 115.51 | 107.47 | Upgrade |
Net Cash (Debt) | -49.39 | -78.43 | -107.49 | -97.54 | -92.03 | Upgrade |
Net Cash Per Share | -3.57 | -5.66 | -7.76 | -7.04 | -6.64 | Upgrade |
Filing Date Shares Outstanding | 13.86 | 13.85 | 13.85 | 13.85 | 13.85 | Upgrade |
Total Common Shares Outstanding | 13.86 | 13.85 | 13.85 | 13.85 | 13.85 | Upgrade |
Working Capital | 81.02 | 64.16 | 35.92 | 27.58 | 14.69 | Upgrade |
Book Value Per Share | 103.22 | 76.05 | 54.20 | 50.01 | 47.75 | Upgrade |
Tangible Book Value | 1,431 | 1,053 | 750.6 | 692.61 | 661.35 | Upgrade |
Tangible Book Value Per Share | 103.22 | 76.05 | 54.20 | 50.01 | 47.75 | Upgrade |
Land | - | 13.62 | 13.62 | 13.62 | 13.62 | Upgrade |
Buildings | - | 15.71 | 15.71 | 15.71 | 14.66 | Upgrade |
Machinery | - | 84.97 | 82.71 | 79.52 | 69.28 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.